Pacific Biosciences of California (PACB) ended the recent trading session at $1.22, demonstrating a +1.67% swing from the preceding day's closing price. The stock's change was less than the S&P 500's ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Greenland sits strategically along two potential routes through the Arctic, which would reduce shipping times between the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PACB stock opened at $1.56 on Tuesday. Pacific Biosciences of California has a 12-month low of $1.16 and a 12-month high of $6.09. The company has a quick ratio of 8.64, a current ratio of 9.74 ...

For just the third time in over 27 years, three tropical cyclones are active simultaneously in the South Pacific. This vast region, which stretches from the Coral Sea in the west to the Pitcairn ...

In the last three months, 4 analysts have published ratings on Pacific Biosciences (NASDAQ:PACB), offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Siegfried Holding AG (SGFEF – Research Report) and Icon ...

Sergott covers the Healthcare sector, focusing on stocks such as Pacific Biosciences, Charles River Labs, and Quest Diagnostics. Icon has an analyst consensus of Strong Buy, with a price target ...